Cite
HARVARD Citation
Oyenuga, M. et al. (2023). Efficacy and safety of Nivolumab in patients with advanced esophageal, gastroesophageal, and gastric cancers: a meta-analysis of randomized controlled trials. Immunopharmacology and immunotoxicology. pp. 10-15. [Online].